The purpose of this trial is to characterize the pharmacokinetics of INS37217 following intravenous, intranasal, and inhalation administration and to calculate the relative bioavailability of INS37217 when administered via oral or nasal inhalation.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
12
plasma concentrations of INS37217
Pilot study - not specified
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.